PedAM

Pediatric Disease Annotations & Medicines

Disease	thalassemia
Phenotype	C0020538\|hypertension
Sentences	11
PubMedID- 21655030	[12] the incidence of pulmonary hypertension in patients with hbs/β -thalassemia is similar to that observed in patients with scd.
PubMedID- 26388975	According to the 60% incidence rate of pulmonary hypertension in patients with thalassemia intermedia, the sample size was calculated to be 60 cases (with a relative accuracy of 25%).
PubMedID- 24330103	Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin e/beta-thalassemia disease.
PubMedID- 22846514	Determinants of pulmonary hypertension in patients with beta-thalassemia major and normal ventricular function.
PubMedID- 22075289	Risk factors for pulmonary hypertension in patients with beta thalassemia intermedia.
PubMedID- 21705990	Case report: thalassemia intermedia patient with hypertension non-responsive to combined medical treatment.
PubMedID- 21712881	[6] we had used both ibp and cvp monitoring because of severe pulmonary artery hypertension (pah) along with associated thalassemia major in our patient.
PubMedID- 25170276	Objective: the aim of the research reported here was to compare pulmonary artery systolic pressure (pasp) and 6-minute walk distance after 1 year of follow-up in hemoglobin e/beta thalassemia (e/beta-thal) with pulmonary arterial hypertension (pah) patients who received chronic blood transfusions versus those who received occasional transfusions.
PubMedID- 20698879	Risk factors for pulmonary hypertension in patients with thalassemia intermedia.
PubMedID- 25386747	A risk score for predicting pulmonary hypertension in patients with non-transfusion-dependent thalassemia in northeastern thailand: the e-saan score.
PubMedID- 25621166	Pulmonary arterial hypertension in a patient with beta-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature.

Page: 1